Literature DB >> 11488333

Eotaxin and monocyte chemoattractant protein-1 in chronic eosinophilic pneumonia.

H Tateno1, H Nakamura, N Minematsu, K Amakawa, T Terashima, S Fujishima, A D Luster, C M Lilly, K Yamaguchi.   

Abstract

Chronic eosinophilic pneumonia (CEP) is characterized by chronic or recurrent pulmonary infiltrates with eosinophils, but the precise mechanism of eosinophil accumulation has not been fully elucidated. Eotaxin is one of the CC chemokines that selectively recruits eosinophils and contributes to the pathogenesis of allergic airway diseases including asthma, but its roles in pathogenesis of CEP have not been fully elucidated. The authors measured concentrations of eotaxin and other CC chemokines, monocyte chemoattractant protein-1 (MCP-1), regulated on activation, normal T-cell expressed and secreted, macrophage inflammatory protein-1alpha, and the eosinophil activating Th2 cytokine interleukin (IL)-5 in bronchoalveolar lavage (BAL) fluid from CEP patients (n=11), and compared these concentrations with those from control subjects (n = 6). The eotaxin (904 +/- 203 versus 29 +/- 7 pg x mL(-1), p = 0.0001), MCP-1 (194 +/- 57 versus 15 +/- 2 pg x mL(-1), p < 0.05), and IL-5 (7.8 +/- 2.0 versus 2.7 +/- 0.6 pg x mL(-1), p < 0.05) levels were significantly higher for cases with CEP in comparison to those serving as controls. Proportions of eosinophil and lymphocyte counts were greater in BAL fluid from CEP patients. Eotaxin and IL-5 levels correlated with the proportion of eosinophils in BAL fluid from CEP patients. MCP-1 correlated with the relative lymphocyte numbers. In short, eotaxin, interleukin-5, and monocyte chemoattractant protein-1 levels were higher in the BAL fluid of CEP patients and these levels may contribute to eosinophil and lymphocyte recruitment and activation in the airways as found with this disorder.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11488333     DOI: 10.1183/09031936.01.17509620

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  6 in total

1.  Eosinophilic Lung Disease: Accompanied with 12 Cases.

Authors:  Tülin Sevim; Emine Aksoy; Fatma Tokgöz Akyıl; Meltem Çoban Ağca; Nilüfer Aykaç Kongar; Ferhan Özşeker
Journal:  Turk Thorac J       Date:  2015-10-01

2.  Allergic lung inflammation promotes atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Cong-Lin Liu; Yi Wang; Mengyang Liao; Marcela M Santos; Cleverson Fernandes; Galina K Sukhova; Jin-Ying Zhang; Xiang Cheng; Chongzhe Yang; Xiaozhu Huang; Bruce Levy; Peter Libby; Gongxiong Wu; Guo-Ping Shi
Journal:  Transl Res       Date:  2016-02-01       Impact factor: 7.012

3.  Increased Serum Levels of Proinflammatory Cytokines Are Accompanied by Fatigue in Military T-6A Texan II Instructor Pilots.

Authors:  Elizabeth G Damato; Seth J Fillioe; Seunghee P Margevicius; Ryan S Mayes; Jonathan E Somogyi; Ian S Vannix; Alireza Abdollahifar; Anthony M Turner; Lidia S Ilcus; Michael J Decker
Journal:  Front Physiol       Date:  2022-04-28       Impact factor: 4.755

Review 4.  Eosinophilic pneumonias.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

5.  Chronic eosinophilic pneumonia in a 13-year-old child.

Authors:  Nadia Nathan; Nathalie Guillemot; Guillaume Aubertin; Sylvain Blanchon; Katarina Chadelat; Ralph Epaud; Annick Clément; Brigitte Fauroux
Journal:  Eur J Pediatr       Date:  2008-01-17       Impact factor: 3.183

Review 6.  Possible Mechanisms of Eosinophil Accumulation in Eosinophilic Pneumonia.

Authors:  Kazuyuki Nakagome; Makoto Nagata
Journal:  Biomolecules       Date:  2020-04-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.